Stock Events

Stock Events

ARCH THERAPEUTICS INC 

$0.000100
0
+$0.00+0% Tuesday 21:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.2899
52W Low
0.0001
Volume
900
Avg. Volume
791
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
82
82.33
82.67
83
Expected EPS
82
Actual EPS
N/A

Financials

-9,188.16%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
152,000Revenue
-13.97MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the medical devices segment, offering products that could compete with Arch's surgical and wound care solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers advanced wound care and surgical solutions, directly competing with Arch Therapeutics' product offerings.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation provides medical solutions that could be used in similar applications as Arch's, particularly in surgical environments.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical and surgical equipment, posing competition to Arch's surgical products and technologies.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. offers advanced recovery and care products, competing in the wound care and surgical product market.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories has a broad range of medical devices and health care solutions that could compete with Arch Therapeutics' offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. provides solutions in musculoskeletal healthcare, which may overlap with Arch's surgical and wound care technologies.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, potentially competing with Arch's approach to improving surgical outcomes.
Cooper Companies
COO
Mkt Cap13.88B
The Cooper Companies operate in medical device sector, offering products that could compete in the surgical and wound care space.
West Pharmaceutical Services
WST
Mkt Cap23.75B
West Pharmaceutical Services, Inc. provides innovative solutions for injectable drug administration, indirectly competing with Arch's technology in terms of delivery and therapeutic outcomes.

About

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
Show more...
CEO
Dr. Terrence W. Norchi M.D.
Employees
8
Country
United States

Listings

0 Comments

Share your thoughts

FAQ

What is ARCH THERAPEUTICS INC stock price today?▼
The current price of ARTHQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch ARCH THERAPEUTICS INC stock price performance more closely on the chart.
What is ARCH THERAPEUTICS INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ARCH THERAPEUTICS INC stocks are traded under the ticker ARTHQ.
Is ARCH THERAPEUTICS INC stock price growing?▼
ARTHQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ARCH THERAPEUTICS INC has showed a +0% increase.
What is ARCH THERAPEUTICS INC revenue for the last year?▼
ARCH THERAPEUTICS INC revenue for the last year amounts to 152,000 USD.
What is ARCH THERAPEUTICS INC net income for the last year?▼
ARTHQ net income for the last year is -13.97M USD.
How many employees does ARCH THERAPEUTICS INC have?▼
As of September 07, 2026, the company has 8 employees.
In which sector is ARCH THERAPEUTICS INC located?▼
ARCH THERAPEUTICS INC operates in the Health & Wellness sector.
When did ARCH THERAPEUTICS INC complete a stock split?▼
The last stock split for ARCH THERAPEUTICS INC was on January 18, 2023 with a ratio of 1:200.
Where is ARCH THERAPEUTICS INC headquartered?▼
ARCH THERAPEUTICS INC is headquartered in Framingham, United States.